ERBB2 and breast cancer: MRI had a higher PPV than US in all tumors (0.83 vs 0.73) and in HR−/HER2+ BC (0.86 vs 0.55) while both methods had a similar PPV in HR+/HER2+ and HR−/HER2− tumors.